An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIA

  • Anna L. Gray
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom
  • Claire O'Leary
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom
  • Aiyin Liao
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom
  • Leticia Agúndez
    Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom
  • Amir S. Youshani
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom
  • Hélène F. Gleitz
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom
  • Helen Parker
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom
  • Jessica T. Taylor
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom
  • Olivier Danos
    Lysogene, Neuilly-sur-Seine, France.
  • Michaël Hocquemiller
    Lysogene, Neuilly-sur-Seine, France.
  • Nuria Palomar
    Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom
  • R. Michael Linden
    Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom
  • Els Henckaerts
    Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom
  • Rebecca J. Holley
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom
  • Brian W. Bigger
    Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom

Search this article

Journal

  • Human Gene Therapy

    Human Gene Therapy 30 (9), 1052-1066, 2019-09-01

    Mary Ann Liebert Inc

Citations (1)*help

See more

Report a problem

Back to top